ERYTECH provides business update and financial results for the first half of 2015 Post author:admERY Post published:September 28, 2015 Post category:Newsroom ERYTECH provides a business update and reports its financial results for the six-month period ending June 30, 2015. You Might Also Like ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia June 9, 2020 Webinar on Eryaspase in Pancreatic Cancer September 2, 2021 ERYTECH announces ADR Level 1 listing in the US January 12, 2015
ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia June 9, 2020
